Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase 2, Phase 3, Recruiting
Mindful Self-Compassion for Anxiety Disorders and Depression
for
Anxiety Disorders, Generalized Anxiety Disorder,
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 18 - 70+
Code: NCT05671419
Recruiting
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
for
Periprosthetic Joint Infections
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Elute, Inc.
Sex: All
Age: 22+
Code: NCT05361941
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase 3, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: Washington D.C. DC, Philadelphia PA, New Brunswick NJ,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase 1, Phase 2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase 1, Phase 2, Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Washington D.C. DC, Fairfax VA, New York NY, Boston MA,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase 1, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue